Inhibitor of neurotransmitters reduces SUI episodes


Chicago-Women with stress urinary incontinence receiving an investigationalagent designed to inhibit two key neurotransmitters significantly showeda reduced number of weekly incontinence episodes and improvements in qualityof life compared with patients receiving placebo. The drug, duloxetine,is dual reuptake inhibitor of serotonin and norepinephrine currently inphase III development.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.